NCT03581006

Brief Summary

This is a randomized-controlled unblinded clinical trial to investigate dietary intervention on metabolic biomarker assessment in World Trade Center (WTC) Lung Injury (LI) in firefighters. The purpose of this study is to evaluate biomarkers of metabolic dysregulation that have previously been found to predict WTC-LI in a case cohort study selected from the entire exposed firefighter cohort, and attempt to alter these metabolites using dietary intervention and a technology-supported behavioral modification program. Investigators will measure Pre/Post global metabolic expression in WTC-exposed, symptomatic firefighter serum sampled after 6-month intervention, as well as clinical outcomes of WTC-LI in the study group vs controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 10, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

November 12, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2021

Completed
Last Updated

December 3, 2021

Status Verified

December 1, 2021

Enrollment Period

2.3 years

First QC Date

June 15, 2018

Last Update Submit

December 1, 2021

Conditions

Keywords

World Trade CenterFirefightersFDNY9/11MetabolomicsFIREHOUSE

Outcome Measures

Primary Outcomes (1)

  • Body mass index (BMI)

    Body mass (weight in kg) divided by square of the body height (measured in meters), expressed in units kg/m\^2

    4 Years

Secondary Outcomes (17)

  • Pulmonary Function using FEV Measure

    4 Years

  • St. George's Respiratory Questionnaire (SGRQ)

    4 Years

  • Electrocardiogram (EKG)

    4 years

  • Fraction of exhaled nitrous oxide (FENO)

    4 years

  • Pulse Wave Velocity (PWV)

    4 years

  • +12 more secondary outcomes

Study Arms (2)

Intervention Group

This observational cohort study will follow firefighters enrolled in Monitoring and Treatment Program. Investigators will include firefighters in the validation cohort who were present at the WTC site within 3 days of 9/11, have consent, and have abnormal post-9/11 lung function. This intervention group will undergo technology based monitoring and behavioral participation in a dietary and exercise program with the intent of weight loss and compliance with a low-calorie Mediterranean diet.

Dietary Supplement: Low-Calorie Mediterranean DietCombination Product: Technology based monitoring and behavioral participation

Control (Usual care) Group

This observational cohort study will follow firefighters enrolled in Monitoring and Treatment Program. Investigators will include firefighters in the validation cohort who were present at the WTC site within 3 days of 9/11, have consent, and have abnormal post-9/11 lung function. This group will receive no dietary or behavioral intervention. They will continue usual care with their home physicians.

Other: Usual care group

Interventions

Participants in the intervention group will receive 6 months of education and behavioral counseling with self-monitoring to help them adopt a Mediterranean-style, calorie-restricted diet, and engage in physical activity

Also known as: LoCalMed
Intervention Group

Intervention participants will use smart phones to connect to intervention applications, WebEx, MyNetDiary

Also known as: LoCalMed
Intervention Group

Control group, who will receive no dietary or behavioral intervention during the trial

Also known as: Control group
Control (Usual care) Group

Eligibility Criteria

Age21 Years - 90 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale only
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

FDNY rescue and recovery worker with 9/11 exposure with documented WTC-LI by spirometry criteria.

You may qualify if:

  • Age 21-90.
  • Born male sex and currently identify as genetic male
  • FDNY rescue and recovery worker.
  • Documented WTC exposure.
  • Enrolled in the FDNY WTC Health Program
  • Subjects are willing and able to consent for themselves to study enrollment
  • Subjects are willing and able to participate in study procedures
  • Are able to perform their activities of daily living independently
  • Are either light duty or retired FDNY Firefighters
  • Have an FEV1 less than the LLN of predicted for age/sex/weight documented at any time after 9/11/2001.
  • Have a BMI\>27 kg/m2 and \<50kg/m2
  • Willing and able to modify their diet and activity level.
  • Subjects who have a spirometry available within the last 36 months, and at their post-9/11 visits at the FDNY
  • Demonstrate minimal proficiency using a smart phone
  • Have means to accommodate transportation to/from in-person visits

You may not qualify if:

  • Have pre-existing and documented conditions or concurrent diagnoses, including (and not necessarily limited to) active cancer, severe heart disease, significant cognitive impairment, eating disorders, significant psychiatric illness, end-stage COPD, severe pulmonary hypertension, or organ transplant.
  • Concomitant use of interfering medication(s) or devices currently or within the month prior to enrollment, including anti-retrovirals, human monoclonal antibodies, supplemental daytime oxygen, and insulin pumps.
  • Severe gastrointestinal issues or illnesses that would prevent adherence to the proposed diets.
  • Severe kidney disease requiring dialysis
  • Severe liver disease requiring frequent medical intervention
  • Participating in other diet modification studies.
  • High dose steroid (\>20mg prednisone or equivalent) or other hormonal treatments/chemotherapy use in the last month, including testosterone supplementation.
  • Life-expectancy \< 6 months
  • BMI ≥50 kg/m2 or ≤27 kg/m2
  • Recent significant intentional or unintentional weight loss, defined as over 5% reduction in total body weight over the last month. (Blackburn Criteria).
  • Significant or severe alcohol abuse disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

FEV1\<LLN to define WTC-LI; resistant subjects had an FEV1\>= LLN at all timepoints post 9/11.

MeSH Terms

Conditions

Lung Injury

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Anna Nolan, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2018

First Posted

July 10, 2018

Study Start

November 12, 2018

Primary Completion

March 4, 2021

Study Completion

March 4, 2021

Last Updated

December 3, 2021

Record last verified: 2021-12

Locations